BioSpace News Archive

Increasing incidence of ulcers have led to investments by healthcare companies in R&D initiatives to develop pressure relief devices that is expected to drive market revenue growth.

Oligon™ Inc., an emerging biotechnology company developing a novel class of multimodal RNA therapeutics for the treatment of cancer and other diseases, announced today that three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022.

OncoSpark, Inc. a leader in value-based-technology enabled services, and MedicoCX, a growing startup agile team working with independent medical practices utilizing respiratory biologics, have joined forces to solve the challenge of prior authorization in the Asthma and Allergy space.

Henlius announced its annual results for the year ended December 31st, 2021, sharing the company’s recent noteworthy progress and achievements.

Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial results for 2021 and provides an update on its product pipeline.

Abivax SA announces its 2021 annual financial results, as of December 31, 2021, and provides an update on the progress of its product pipeline.

New Agreement with Federal Equipment Company Expands Companies Capabilities.

Zymergen Inc. announced it will report preliminary financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 22nd, 2022.

Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, announced that the company will participate in the KeyBanc Capital Markets Life Sciences & MedTech Forum.

ulrich medical USA, Inc. announced the 2022 faculty and program highlights for the Sixth Cage Madness Spine Education Forum and Bioskills Training to be held in Las Vegas, Nevada on March 19, 2022.